F/M Investments’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
235,085
+70,164
+43% +$465K 0.07% 154
2026
Q1
$1.2M Sell
164,921
-230,973
-58% -$3.01M 0.08% 152
2025
Q4
$6.73M Buy
395,894
+77,807
+24% +$791K 0.26% 97
2025
Q3
$2.33M Buy
318,087
+74,410
+31% +$602K 0.09% 222
2025
Q2
$1.58M Buy
243,677
+3,259
+1% +$21.5K 0.06% 265
2025
Q1
$1.94M Buy
240,418
+14,384
+6% +$157K 0.08% 234
2024
Q4
$2.8M Buy
+226,034
New +$3.02M 0.1% 183

Other funds holding WVE

F/M Investments's WVE Position: Q2 2026 in Review

F/M Investments increased its Wave Life Sciences (WVE) stake by 43% in Q2 2026, buying an estimated $465K and bringing the position to 235,085 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #154.

F/M Investments first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.73M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • F/M Investments held 235,085 shares of Wave Life Sciences worth $1.37M as of Q2 2026.
  • F/M Investments bought 70,164 Wave Life Sciences shares in Q2 2026, an estimated $465K.
  • Wave Life Sciences made up 0.07% of F/M Investments's portfolio in Q2 2026, its #154 holding.
  • F/M Investments first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • F/M Investments's Wave Life Sciences position peaked at $6.73M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.